Journals / Journal of Basic and Clinical Health Sciences / 2020 / Cilt: 4 - Sayı: 3

Effects of Pain, Depression and Quality of Life on Bone Mineral Density in Patients with Fibromyalgia

Pages
280–287
Publication Date
2020-09-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This study confirmed the concept that FMS is a risk factor for osteoporosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this study, we aimed to assess the effects of bone mineral density with fibromyalgia on pain, depression and quality of life.
📊
Key Findings & Data:Methods: In this case-control study, 100 women who were diagnosed as FMS and 100 women who were not diagnosed as FMS were included.
💡
Conclusion & Impact:This study confirmed the concept that FMS is a risk factor for osteoporosis.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:fibromyalgia syndrome · bone mineral density · pain

Abstract

Objective: In this study, we aimed to assess the effects of bone mineral density with fibromyalgia on pain, depression and quality of life. Methods: In this case-control study, 100 women who were diagnosed as FMS and 100 women who were not diagnosed as FMS were included. Visual Analog Scala VAS , Fibromyalgia Impact Questionnaire FIQ and Hospital Anxiety and Depression Scala HADS were used for the patients. Bone mineral density BMD of the participants was measured with dual energy x ray absorptiometry DXA method. Results: The number of the tender points of the women with fibromyalgia and VAS, FIQ, HAD-A and HAD-D scores were found significantly higher than of the control group p0.05 . When BMD measurements and HAD-A and HAD-D scores of the fibromyalgia patients were compared; in the L1-L4 region of the patients with anxiety and depression; BMD mass, T score and Z score were found respectively lower than of those without anxiety and depression p=0.011 p=0.040 . Conclusions: The FIQ scores of the patients with low L1-L4 T scores were found higher than of the patients with normal T scores. The L1-L4 region of the patients with anxiety and depression; BMD mass, T score and Z score were found respectively lower than of those without anxiety and depression. This study confirmed the concept that FMS is a risk factor for osteoporosis.

🔖

Cite This Article

DEMİRBAS, N., KUTLU, R., ECESOY, H. (2020). Effects of Pain, Depression and Quality of Life on Bone Mineral Density in Patients with Fibromyalgia. Journal of Basic and Clinical Health Sciences, Cilt: 4 - Sayı: 3, 280–287. https://ajindex.com/articles/163505

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Bellato E, Marini E, Castoldi F, et al. Fibromyalgia Syndrome: Etiology, pathogenesis, diagnosis, and treatment. Pain Res Treat 2012;2012:426130. [CrossRef] 2. Jones GT, Atzeni F, Beasley M, Flüß E, Sarzi-Puttini P, Macfarlane GJ. The prevalence of fibromyalgia in the general population - a comparison of the American College of Rheumatology 1990, 2010 and modified 2010 classification criteria. Arthritis Rheumatol 2015;67:568–575. [CrossRef] 3. Verbunt JA, Pernot DH, Smeets RJ. Disability and quality of life in patients with fibromyalgia. Health Qual Life Outcomes 2008;22;6:8. [CrossRef] 4. Soran N, Altındağ O, Demirkol A. Depression level and relation with clinical parameters in fibromyalgia syndrome. Rheumatism 2008;23:1–4. https://archivesofrheumatology.org/abstract/243 5. Dessein PH, Stanwix AE. Why would fibromyalgia patients have osteoporosis? J Rheumatol 2000;27:1816–1817. https://pubmed. ncbi.nlm.nih.gov/10914876/ 6. Upala S, Yong WC, Sanguankeo A. Bone mineral density is decreased in fibromyalgia syndrome: a systematic review and meta-analysis. Rheumatol Int 2017;37:617–622. [CrossRef] 7. Lee YH, Song GG. Association between low bone mineral density and fibromyalgia: a meta-analysis. Clin Rheumatol 2017;36:2573–2579. [CrossRef] 8. Topbas M, Cakırbay H, Gulec H, Akgol E, Ak I, Can G. The prevalance of fibromyalgia in women aged 20–64 in Turkey. Scand J Rheumatol 2005;34:140–144. https://pubmed.ncbi.nlm.nih. gov/16095011/ 9. Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: development and validation. J Rheumatol 1991;18:728–733. https://pubmed.ncbi.nlm.nih.gov/1865419/ 10. Sarmer S, Ergin S, Yavuzer G. The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int 2000;20:9–12. [CrossRef] 11. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361–370. [CrossRef] 12. Aydemir O, Güvenir T, Küey L, Kültür S. Reliability and Validity of the Turkish version of Hospital Anxiety and Depression Scale. Turk J Psychiatry 1997;8:280–287. http://www.turkpsikiyatri.com/en/ default.aspx?modul=summary&id=191 13. International Society for Clinical Densitometry (ISCD). 2013 ISCD Official Positions - Adult; 2013. http://www.iscd.org/ officialpositions/2013-iscd-official-positions-adult 14. Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity.